Effectiveness and Safety of Semaglutide for Weight Loss in Patients With Inflammatory Bowel Disease and Obesity.
Aakash DesaiHimsikhar KhataniarJana G HashashFrancis A FarrayeMiguel RegueiroGursimran S KochharPublished in: Inflammatory bowel diseases (2024)
Semaglutide use is effective in patients with IBD and obesity similar to patients without IBD, with >5% mean weight loss. There was no increased risk of IBD-specific adverse events with semaglutide use.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- patients with inflammatory bowel disease
- end stage renal disease
- insulin resistance
- weight gain
- metabolic syndrome
- chronic kidney disease
- newly diagnosed
- ejection fraction
- type diabetes
- glycemic control
- ulcerative colitis
- peritoneal dialysis
- high fat diet induced
- prognostic factors
- patient reported outcomes
- body mass index
- skeletal muscle
- adipose tissue